The World Health Organization has reported that when morphine is used to control pain in cancer patients, psychological dependence is not a major concern. Our studies were undertaken to ascertain the modulation of psychological dependence on morphine under a chronic pain-like state in rats. Morphine induced a dose-dependent place preference. We found that in‰ammatory and neuropathic pain-like states signiˆcantly suppressed the morphine-induced rewarding eŠect. In an in‰ammatory pain-like state, the suppressive eŠect was signiˆcantly recovered by treatment with a k-opioid receptor antagonist. In addition, in vivo microdialysis studies clearly showed that the morphine-induced increase in the extracellular levels of dopamine (DA) in the nucleus accumbens (N.Acc.) was signiˆcantly decreased in rats pretreated with formalin. This eŠect was in turn reversed by the microinjection of a speciˆc dynorphin A antibody into the N.Acc. Theseˆndings suggest that the in‰ammatory pain-like state may have caused the sustained activation of the k-opioidergic system within the N.Acc., resulting in suppression of the morphine-induced rewarding eŠect in rats. On the other hand, we found that attenuation of the morphine-induced place preference under neuropathic pain may result from a decrease in the morphine-induced DA release in the N.Acc with a reduction in the m-opioid receptor-mediated G-protein activation in the ventral tegmental area (VTA). Moreover, nerve injury results in the continuous release of endogenous b-endorphin to cause the dysfunction of m-opioid receptors in the VTA. This paper also provides a review to clarify misunderstandings of opioid analgesic use to control pain in cancer patients.

